AstraZeneca

In the last 4 hours

AstraZeneca, Merck duke it out at the top of oncologists’ pharma perception ranking FiercePharma16:45

I asked ChatGPT for the best UK shares to buy now — its top pick surprised me… Motley Fool (UK)16:42

In the last 6 hours

Fighting for Those Who've Fought for Us: ZERO Prostate Cancer and AstraZeneca Drive Urgent Call … PR Newswire (Press Release)14:56

In the last 8 hours

AZ partners with Aptar on kidney disease-detecting AI pharmaphorum14:01

Aptar Digital Health Announces Licensing Agreement With AstraZeneca to Develop AI-Powered… Business Wire (Press Release)13:01

AstraZeneca shares late-stage results for Airsupra in mild asthma patients PMLiVE12:38

Earlier today

Zentiva inks €220M deal to commercialize AstraZeneca GI cast-off in Europe FiercePharma09:18

J&J launches Yuhan-partnered lung cancer combo in Japan as AstraZeneca secures Tagrisso expansion Korea Biomedical Review05:18

Yesterday

The Zacks Analyst Blog Highlights Visa, AstraZeneca, Shell, Ocean Power Technologies and Wheeler Real Estate Investment … Zacks15:17 21-May-25

AstraZeneca Stock Declines 6% in 3 Months: Time to Buy the Dip? Zacks15:07 21-May-25

In brief: AstraZeneca chief executive joins Agilent Technologies board London South East14:33 21-May-25

AstraZeneca CEO Joins Agilent Technologies Board TipRanks14:07 21-May-25

AstraZeneca’s record seventh year of plenary data at ASCO furthers ambition to redefine breast cancer care and… AstraZeneca (Press Release)09:45 21-May-25

In the last 7 days

Top Research Reports for Visa, AstraZeneca & Shell Zacks22:58 20-May-25

AstraZeneca means 'a road to death' in Latin? Snopes.com11:08 20-May-25

Acquisition of EsoBiotec completed AstraZeneca (Press Release)09:43 20-May-25

AstraZeneca completes EsoBiotec acquisition for up to USD1 billion London South East09:05 20-May-25

AstraZeneca agrees £750m deal for EsoBiotec BusinessCloud.co.uk07:38 20-May-25

ATS 2025: Tezepelumab reduces COPD exacerbations in eosinophilic patients, despite CB Pharmaceutical Technology00:02 20-May-25

In brief: AstraZeneca trial shows Airsupra effective against asthma London South East20:03 19-May-25

‘Unprecedented’ Data Lift AstraZeneca’s Ambitions For Airsupra Scrip Pharma Intelligence18:18 19-May-25

Statistically significant and clinically meaningful Batura Phase III trial results provide new… Business Wire (Press Release)17:36 19-May-25

AstraZeneca's Airsupra cuts risk of severe exacerbations by 47% in patients with milder asthma FiercePharma17:25 19-May-25

Adult Vaccine Market Forecast Report and Company Analysis 2025-2033 Featuring GlaxoSmithKline,… Business Wire (Press Release)16:35 19-May-25

Third Circuit Affirms Rejection of AstraZeneca’s Challenges to IRA Drug Price Negotiation Program JD Supra19:39 16-May-25

Durvalumab Regimen Improves Disease-Free Survival in High-Risk Non-Muscle-Invasive Bladder Cancer Pharmacy Times17:14 16-May-25

Antibody Conjugate Oligonucleotide Market Research 2025-2035, Competitive Analysis of Key… Business Wire (Press Release)15:50 16-May-25

Executives On The Move: Pathos Procures CEO From AstraZeneca, New CEO For TME Pharma, And More Scrip Pharma Intelligence15:09 16-May-25

Spotlighting Innovations in Pulmonary Care at ATS 2025 American Journal of Managed Care15:08 16-May-25

Aptamer announces new data at ASGCT European Pharmaceutical Manufacturer15:06 16-May-25

Eosinophilic Esophagitis Market Set to Surge as New Research Unveils Breakthrough Treatments |… PR Newswire (Press Release)22:52 15-May-25

York firm reports progress with 'multi-billion dollar' liver treatment opportunities York Press10:59 15-May-25

AZ's needle-free, intranasal flu vaccine wins Korean approval Korea Biomedical Review06:25 15-May-25

Alteogen’s breakout Q1 overshadowed by US scrutiny of subcutaneous drug combos Korea Biomedical Review05:12 15-May-25

In the last month

AstraZeneca’s New $300M Plant Provides Control of Cell Therapy Production Genetic Engineering and Biotechnology News17:47 14-May-25

Abu Dhabi Public Health Centre, AstraZeneca forge strategic partnership AniNews.in22:52 13-May-25

Global Coalition for Adaptive Research Announces Initiation of AZD1390 in GBM AGILE Trial PR Newswire (Press Release)16:00 13-May-25

AstraZeneca announces positive phase 3 results for Imfinzi in high-risk bladder cancer PMLiVE12:29 13-May-25

AstraZeneca to showcase latest research on comprehensive portfolio and pipeline aimed at transforming respiratory… AstraZeneca (Press Release)11:39 13-May-25

MHRA approves AstraZeneca’s Trixeo Aerosphere inhaler for COPD Pharmaceutical Technology11:06 13-May-25

21 analysts advised buy AstraZeneca shares in January – see what £10k invested then is worth now Motley Fool (UK)08:04 13-May-25

World-first approval supports AstraZeneca’s sustainability goals European Pharmaceutical Review00:17 13-May-25

AstraZeneca and GSK in the firing line as Trump targets big pharma: Alex Brummer This is Money22:08 12-May-25

Appeals Court Rejects AstraZeneca’s Challenge to Medicare Drug Price Negotiation Program National Law Review19:43 12-May-25

UK approves AZ inhaler with 'greener' propellant pharmaphorum13:17 12-May-25

Why did the AstraZeneca share price just fall, and what should we do? Motley Fool (UK)12:55 12-May-25

AstraZeneca’s Imfinzi combo shows DFS improvement in bladder cancer trial Clinical Trials Arena11:40 12-May-25

Trixeo Aerosphere approved in the UK as first inhaled respiratory medicine using next-generation propellant with… AstraZeneca (Press Release)11:34 12-May-25

'World first': AstraZeneca granted UK license for 'near-zero' emission inhaler medicine BusinessGreen11:30 12-May-25

AstraZeneca gets UK approval for Trixeo with eco-friendly propellant London South East09:17 12-May-25

GSK and Astrazeneca shares slump as Trump vows drug price cut City AM09:15 12-May-25

AstraZeneca (LSE:AZN) Reports Positive Results From Phase III IMFINZI Trial In Bladder Cancer Simply Wall St21:21 10-May-25

EU Approves AstraZeneca Mantle Cell Lymphoma Treatment PharmTech.com17:03 9-May-25

How Much Upside is Left in Astrazeneca (AZN)? Wall Street Analysts Think 27.89% Zacks16:01 9-May-25

AstraZeneca opens the door to Imfinzi expansion with trial win in high-risk bladder cancer… FiercePharma15:18 9-May-25

AstraZeneca breaks ground on new factory in east China Xinhua Agency12:59 9-May-25

AZ plots wider Imfinzi use in bladder cancer after trial win pharmaphorum11:32 9-May-25

AstraZeneca receives positive bladder cancer trial data for Imfinzi London South East09:35 9-May-25

AstraZeneca’s Imfinzi delays bladder cancer return in high-risk patients Proactive Investors (UK)07:59 9-May-25

AstraZeneca reports positive results from bladder cancer trial ShareCast07:35 9-May-25

AstraZeneca loses appeals court fight over IRA drug price negotiations ENDPOINTS19:26 8-May-25

AstraZeneca Loses Bid to Revive Drug Price Suit at Third Circuit Bloomberg Law15:40 8-May-25

Tempus AI Stock: Time to Double Down or Cut and Run? Entrepreneur Magazine13:10 8-May-25

AstraZeneca invests €600 million in new hub in Lisbon Portugal Resident12:02 8-May-25

AstraZeneca and Daiichi’s Enhertu shows pCR rate improvement in breast cancer trial Clinical Trials Arena11:39 8-May-25

Cervical Cancer Treatment Global Market Overview 2024-2030 Featuring AbbVie, Alnylam,… Business Wire (Press Release)10:57 8-May-25

AstraZeneca/Daiichi Sankyo share positive phase 3 results for Enhertu in early breast cancer PMLiVE08:46 8-May-25

[BIO KOREA 2025] AstraZeneca brings BioVentureHub model to Korea with trust-first startup partnerships Korea Biomedical Review06:26 8-May-25

Does the GSK or AstraZeneca share price currently offer the best value? Motley Fool (UK)06:21 8-May-25

IonQ Leads Quantum Revolution: From Computing to Global Innovation WebProNews17:25 7-May-25

AstraZeneca, Daiichi Sankyo's Enhertu rings up success in another breast cancer trial FiercePharma16:12 7-May-25

First Win For AstraZeneca’s Enhertu In Early-Stage Breast Cancer Treatment Scrip Pharma Intelligence13:20 7-May-25

New data could move Enhertu into early breast cancer pharmaphorum13:05 7-May-25

GSK, AstraZeneca slide after FDA unveils new vaccine lead ShareCast11:36 7-May-25

Investors await Fed decision, GSK and AstraZeneca weigh on F... IG11:04 7-May-25

AstraZeneca and GSK slide as Trump and RFK appoint new FDA vaccine chief Proactive Investors (UK)11:02 7-May-25

Today's markets: Will pharma stocks stop the FTSE run? Investors Chronicle10:57 7-May-25

Tempus AI Strikes $200M Deal With AstraZeneca, Pathos To Build World's Largest Oncology Model Benzinga10:23 7-May-25

EC approves AstraZeneca’s Calquence combo to treat MCL Pharmaceutical Technology10:13 7-May-25

AstraZeneca touts positive trial data for breast cancer treatment London South East09:36 7-May-25

AstraZeneca receives 'positive high-level results' results from Enhertu trial ShareCast09:27 7-May-25

AstraZeneca’s Enhertu Shows Promise in Early-Stage Breast Cancer Trial TipRanks07:34 7-May-25

Calquence plus chemoimmunotherapy approved in the EU as first and only BTK inhibitor for 1st-line mantle cell lymphoma AstraZeneca (Press Release)06:32 7-May-25

Arcus Biosciences Reports First-Quarter 2025 Financial Results and Provides a Pipeline Update Business Wire (Press Release)21:16 6-May-25

News Medical: Clinical trial underway to assess effectiveness and safety of potential Long Covid treatment The ME Association (Press Release)16:42 6-May-25

AstraZeneca debuts $300M cell therapy manufacturing facility in Maryland FiercePharma13:24 6-May-25

AstraZeneca’s Calquence approved by EC for first-line mantle cell lymphoma use PMLiVE12:41 6-May-25

AstraZeneca's Calquence gets EU approval to treat adults with MCL London South East09:52 6-May-25

AstraZeneca's Calquence gets Europe approval for MCL ShareCast09:19 6-May-25

Intertek agrees acquisition of Tesis, AstraZeneca's Calquence gets fresh Europe approval ShareCast08:07 6-May-25

Ousia Pharma Secures Substantial Seed Financing Led by Omega Funds to Advance Groundbreaking… PR Newswire (Press Release)08:03 6-May-25

Inside The Cell Therapeutics Plant Kicking Off AstraZeneca's $3.5B U.S. Push Bisnow07:58 6-May-25

AstraZeneca’s Calquence Approved in EU for First-Line Mantle Cell Lymphoma TipRanks07:17 6-May-25

AstraZeneca Pharma India's (NSE:ASTRAZEN) earnings growth rate lags the 46% CAGR delivered to shareholders Simply Wall St11:20 5-May-25

AstraZeneca calls for increase EU drug prices to offset effect of US tariffs Cambridge Independent11:10 5-May-25

After AstraZeneca tells investors to stay away, Aston Martin and BAE Systems move annual general meetings online This is Money21:55 3-May-25

AstraZeneca (LSE:AZN) Announces Positive Results From Breztri Trials For Uncontrolled Asthma Simply Wall St20:35 2-May-25

AstraZeneca's Breztri aces 2 asthma trials, lining it up for label expansion FiercePharma16:32 2-May-25

Pathos AI gets AstraZeneca funding as biotech plans to raise up to $400M ENDPOINTS16:01 2-May-25

AstraZeneca's Triple-Combination Therapy Breztri Hits Primary Goals In Two Pivotal Studies For Asthma Benzinga15:35 2-May-25

Trials set up filings for AZ's triple therapy in asthma pharmaphorum14:23 2-May-25

Fierce Pharma Asia—Akeso bispecific's first survival readout; AstraZeneca's China probes; Ono's … FiercePharma13:08 2-May-25

Astrazeneca, Qure.ai Complete 5 million AI-enabled chest X-ray Scans Analytics India Magazine12:23 2-May-25

AstraZeneca’s triple-combination COPD therapy shows promise in uncontrolled asthma PMLiVE12:15 2-May-25

Breztri met primary endpoints in Kalos and logos Phase III trials in asthma Business Wire (Press Release)12:05 2-May-25

AstraZeneca’s triple-combo triumphs in two Phase III asthma trials Clinical Trials Arena12:05 2-May-25

AstraZeneca asthma drug meets targets in phase 3 trials London South East10:13 2-May-25

AstraZeneca's Breztri meets all primary endpoints in asthma trials ShareCast10:07 2-May-25

AstraZeneca’s Breztri Succeeds in Phase III Asthma Trials TipRanks07:18 2-May-25

AstraZeneca Korea, Oncosoft team up to enhance NF1 treatment with AI Korea Biomedical Review05:33 2-May-25

ii view: AstraZeneca enters 'catalyst-rich period' interactive investor16:37 1-May-25

AstraZeneca Director Invests in Company Shares TipRanks16:13 1-May-25

AstraZeneca Announces Current Voting Rights and Share Capital Structure TipRanks15:12 1-May-25

AstraZeneca, Qure.ai complete AI-enabled assessment of 5 million chest X-rays for lung cancer The Hindu Business Line10:11 1-May-25

Up 7.5% in a week! Is the GSK share price about to do an AstraZeneca? Motley Fool (UK)09:55 1-May-25

view more headlines

22 May 16:45

About our AstraZeneca news

Latest news on AstraZeneca, an Anglo-Swedish multinational pharmaceutical and biotechnology company based in Cambridge, with live updates on products and research.

Publication filters

Sorry, no headlines or news topics were found. Please try different keywords.